Akerocapsule (Acebrophylline)

Adult dose

Adults: Administer 100 mg of acebrophylline orally twice daily.

This medication should not be used in patients with hypersensitivity to this medication or its components, other xanthine derivatives, or those with hypersensitivity to ambroxol; patients with acute myocardial infarction, hypotension, severe liver or kidney dysfunction, or nursing mothers. Additionally, this medication contains lactose and should not be administered to patients with genetic conditions such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. Patients with heart disease, coronary insufficiency, congestive heart failure, obesity, a history of epilepsy, gastric or duodenal ulcers, hyperthyroidism, the elderly, children, hypertension, severe hypoxemia, chronic obstructive pulmonary disease, liver or kidney dysfunctions, and pregnant or potentially pregnant women should use this medication with caution. During treatment, symptoms such as nausea or dizziness may occur, and gastrointestinal symptoms such as abdominal discomfort, abdominal pain, diarrhea, vomiting, and heartburn may rarely appear. Additionally, allergic reactions such as rash, urticaria, itching, facial swelling, and difficulty breathing may occur, and if these symptoms appear, the medication should be discontinued immediately. This medication can be toxic if blood concentration increases, so special caution is required in the elderly, patients with liver or kidney dysfunction, and those with alcohol dependence. This medication may interact with other drugs, so when taken alongside erythromycin, cephalexin, and cimetidine, it may be necessary to adjust the dosage of this medication. It is recommended not to use this medication during pregnancy, except in special cases, and should not be taken while breastfeeding. Elderly and pediatric patients require dosage adjustment and careful monitoring when receiving this medication. In case of overdose, severe convulsions or cardiac arrhythmias may occur, and immediate medical assistance is required, after which treatment should be resumed at a lower dose. This medication should be kept out of reach of children and care should be taken not to transfer it to other containers, as this may adversely affect safety and quality.

• temporary area
• dizziness
• abdominal discomfort
• gastric and abdominal distension
• gastric and abdominal pain
• diarrhea
• constipation
• nausea
• vomiting
• hematemesis

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature.

Appearance

Capsule filled with white to off-white powder, with a grey upper half and white lower half

Package unit

Bottle - 30 capsules/bottle, Bottle - 300 capsules/bottle